Tonix Pharmaceuticals
TNXP
22 hedge funds and large institutions have $43.7M invested in Tonix Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 4 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
22% more funds holding
Funds holding: 18 → 22 (+4)
0% more ownership
Funds ownership: 0% → 0% (+0%)
15% less capital invested
Capital invested by funds: $51.2M → $43.7M (-$7.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$6.04M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$3.18M |
| 3 |
Renaissance Technologies
New York
|
+$2.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.91M |
| 5 |
BlackRock
New York
|
+$1.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$325K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$318K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$318K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$318K |
| 5 |
VF
Virtu Financial
New York
|
-$318K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
76
Harbour Investments
Madison,
Wisconsin
| $1K | – | – | – |
|
|
IA
77
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
78
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $68 | – | – | – |
|
|
79
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$325K | -1 | Closed |
|
|
GPFA
80
Game Plan Financial Advisors
Westlake,
Ohio
| – | -$16K | – | – |
|
|
GG
81
Gofen & Glossberg
Chicago,
Illinois
| – | -$15K | – | – |
|
|
HWA
82
HCR Wealth Advisors
Los Angeles,
California
| – | -$12K | – | – |
|
83
Millennium Management
New York
| – | -$137K | – | – |
|
|
PWM
84
Prentice Wealth Management
Rochester,
New York
| – | -$1K | – | – |
|
85
Two Sigma Investments
New York
| – | -$13K | – | – |
|
|
WG
86
Winton Group
London,
United Kingdom
| – | -$37K | – | – |
|
TNXP Hedge Fund Activity: Q4 2021 in Review
22 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2021, worth a combined $43.7M — down 15% from $51.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TNXP positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 1 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $6.04M. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $325K sold.
- 22 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2021, up from 18 in Q3 2021.
- Funds reported $43.7M of Tonix Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
- 8 funds opened new Tonix Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +4 holders.
- The largest Tonix Pharmaceuticals buyer in Q4 2021 was D.E. Shaw & Co, an estimated $6.04M added.
- The largest Tonix Pharmaceuticals seller in Q4 2021 was Qube Research & Technologies (QRT), an estimated $325K sold.
Based on aggregated 13F filings for Q4 2021.